Advertisement

Topics

Artificial Intelligence in Drug Development Congress - Final Agenda

14:30 EDT 28 Jul 2017 | The Journal of mHealth

Oxford Global is pleased to share with you the final agenda for our highly anticipated Artificial Intelligence in Drug Development Congress taking place 27 – 28 September 2017 in London.Join us across two days to discuss with over 200 delegates the innovative application of artificial intelligence in drug development and clinical research. Alongside innovative case studies on the use of artificial intelligence in clinical data, there is a dedicated stream on the latest AI methodologies –

Original Article: Artificial Intelligence in Drug Development Congress - Final Agenda

NEXT ARTICLE

More From BioPortfolio on "Artificial Intelligence in Drug Development Congress - Final Agenda"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...